Open AccessWhat are Canadian primary care physicians prescribing for the treatment of gonorrhea?
Author(s) -
Sandeul Ha,
Lisa Pogany,
J Seto,
Jun Wu,
M Gale-Rowe
Publication year - 2017
Publication title -
canada communicable disease report
Language(s) - English
Resource type - Journals
eISSN - 1481-8531
pISSN - 1188-4169
DOI - 10.14745/ccdr.v43i02a01
Subject(s) - gonorrhea , medicine , azithromycin , family medicine , population , chlamydia , public health , men who have sex with men , health care , environmental health , antibiotics , syphilis , nursing , human immunodeficiency virus (hiv) , economics , microbiology and biotechnology , immunology , biology , economic growth
Cases of Neisseria gonorrhea are on the rise in Canada, which-if undetected or undertreated-can lead to morbidity and infertility. In addition, the number of antimicrobial resistant strains is also increasing creating the risk that N. gonorrhea may become untreatable. In 2013, the Public Health Agency of Canada (PHAC) released Canadian recommendations for the management and treatment of gonorrhea that identified the need for combination therapy to address and minimize antimicrobial resistance. However, the level of awareness and uptake of these guidelines is not well-known.